184 related articles for article (PubMed ID: 36309102)
1. Genomic Characterization of Prostatic Basal Cell Carcinoma.
Low JY; Ko M; Hanratty B; Patel RA; Bhamidipati A; Heaphy CM; Sayar E; Lee JK; Li S; De Marzo AM; Nelson WG; Gupta A; Yegnasubramanian S; Ha G; Epstein JI; Haffner MC
Am J Pathol; 2023 Jan; 193(1):4-10. PubMed ID: 36309102
[TBL] [Abstract][Full Text] [Related]
2. Mutational and transcriptomic landscapes of a rare human prostate basal cell carcinoma.
Su X; Long Q; Bo J; Shi Y; Zhao LN; Lin Y; Luo Q; Ghazanfar S; Zhang C; Liu Q; Wang L; He K; He J; Cui X; Yang JYH; Han ZG; Yang G; Sha JJ
Prostate; 2020 May; 80(6):508-517. PubMed ID: 32119131
[TBL] [Abstract][Full Text] [Related]
3. Pleomorphic basal cell carcinoma.
Garcia JA; Cohen PR; Herzberg AJ; Wallis ME; Rapini RP
J Am Acad Dermatol; 1995 May; 32(5 Pt 1):740-6. PubMed ID: 7722018
[TBL] [Abstract][Full Text] [Related]
4. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
5. Basal cell carcinomas of the scalp after radiotherapy for tinea capitis in childhood: A genetic and epigenetic study with comparison with basal cell carcinomas evolving in chronically sun-exposed areas.
Cardoso JC; Ribeiro IP; Caramelo F; Tellechea O; Barbosa de Melo J; Marques Carreira I
Exp Dermatol; 2021 Aug; 30(8):1126-1134. PubMed ID: 33205471
[TBL] [Abstract][Full Text] [Related]
6. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
7. Genomic Profiling of Metastatic Basal cell Carcinoma Reveals Candidate Drivers of Disease and Therapeutic Targets.
Vergara IA; Aivazian K; Carlino MS; Guminski AD; Maher NG; Shannon KF; Ch'ng S; Saw RPM; Long GV; Wilmott JS; Scolyer RA
Mod Pathol; 2023 Apr; 36(4):100099. PubMed ID: 36788083
[TBL] [Abstract][Full Text] [Related]
8. Recurrent NMYC copy number gain and high protein expression in basal cell carcinoma.
Freier K; Flechtenmacher C; Devens F; Hartschuh W; Hofele C; Lichter P; Joos S
Oncol Rep; 2006 May; 15(5):1141-5. PubMed ID: 16596176
[TBL] [Abstract][Full Text] [Related]
9. Genomic profiling of late-onset basal cell carcinomas from two brothers with nevoid basal cell carcinoma syndrome.
Hasan Ali O; Yurchenko AA; Pavlova O; Sartori A; Bomze D; Higgins R; Ring SS; Hartmann F; Bühler D; Fritzsche FR; Jochum W; Navarini AA; Kim A; French LE; Dermitzakis E; Christiano AM; Hohl D; Bickers DR; Nikolaev SI; Flatz L
J Eur Acad Dermatol Venereol; 2021 Feb; 35(2):396-402. PubMed ID: 32564428
[TBL] [Abstract][Full Text] [Related]
10. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
Bartoš V
Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
[TBL] [Abstract][Full Text] [Related]
11. Understanding the Molecular Genetics of Basal Cell Carcinoma.
Pellegrini C; Maturo MG; Di Nardo L; Ciciarelli V; Gutiérrez García-Rodrigo C; Fargnoli MC
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29165358
[TBL] [Abstract][Full Text] [Related]
12. Multiple Origin and Tumor Heterogeneity of Prostatic Ductal Adenocarcinoma in the Han Chinese Population.
Zhang W; Su F; Wang M; Hou H; Liu M; Liu D; Liu H
Genet Test Mol Biomarkers; 2021 Nov; 25(11):727-732. PubMed ID: 34788144
[No Abstract] [Full Text] [Related]
13. Basal Cell Carcinoma Gene Mutations Differ Between Asian, Hispanic, and Caucasian Patients: A Pilot Study.
Lobl M; Hass B; Clarey D; Higgins S; Sutton A; Wysong A
J Drugs Dermatol; 2021 May; 20(5):504-510. PubMed ID: 33938707
[TBL] [Abstract][Full Text] [Related]
14. Expression of mismatch repair enzymes, hMLH1 and hMSH2 is not associated with microsatellite instability and P53 protein accumulation in basal cell carcinoma.
Saetta AA; Aroni K; Stamatelli A; Lazaris AC; Patsouris E
Arch Dermatol Res; 2005 Sep; 297(3):99-107. PubMed ID: 16012876
[TBL] [Abstract][Full Text] [Related]
15. MYB-NFIB gene fusion in prostatic basal cell carcinoma: clinicopathologic correlates and comparison with basal cell adenoma and florid basal cell hyperplasia.
Magers MJ; Iczkowski KA; Montironi R; Grignon DJ; Zhang S; Williamson SR; Yang X; Wang M; Osunkoya AO; Lopez-Beltran A; Hes O; Eble JN; Cheng L
Mod Pathol; 2019 Nov; 32(11):1666-1674. PubMed ID: 31189999
[TBL] [Abstract][Full Text] [Related]
16. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
Bartoš V; Kullová M
Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
[TBL] [Abstract][Full Text] [Related]
17. Molecular signatures linked with aggressive behavior in basal cell carcinoma: a report of 6 cases.
Fernandes H; Fernandes N; Bhattacharya S; Chen W; Seth A; Hameed M; Mirani N; Lambert WC
Am J Dermatopathol; 2010 Aug; 32(6):550-6. PubMed ID: 20489570
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial D310 D-Loop instability and histological subtypes in radiation-induced cutaneous basal cell carcinomas.
Boaventura P; Pereira D; Mendes A; Batista R; da Silva AF; Guimarães I; Honavar M; Teixeira-Gomes J; Lopes JM; Máximo V; Soares P
J Dermatol Sci; 2014 Jan; 73(1):31-9. PubMed ID: 24091058
[TBL] [Abstract][Full Text] [Related]
19. Basal cell carcinoma of the prostate: a case report responding to the FGFR inhibitor pemigatinib and literature review.
Rebhan K; Wasinger G; Hassler MR; Shariat SF; Compérat EM
Curr Opin Urol; 2022 Jul; 32(4):358-363. PubMed ID: 35749783
[TBL] [Abstract][Full Text] [Related]
20. Detection of loss of heterozygosity on chromosome 9q22.3 in microdissected sporadic basal cell carcinoma.
Shen T; Park WS; Böni R; Saini N; Pham T; Lash AE; Vortmeyer AO; Zhuang Z
Hum Pathol; 1999 Mar; 30(3):284-7. PubMed ID: 10088546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
